MedPath

A Short-Term Appetite Suppression Trial Using Appethyl™: The Pizza

Not Applicable
Completed
Conditions
Overweight
Obesity
Interventions
Dietary Supplement: Appethyl™
Other: Placebo
Registration Number
NCT01919814
Lead Sponsor
Pennington Biomedical Research Center
Brief Summary

The purpose of the study is to determine whether Appethyl™, made from spinach, will reduce appetite and hunger given on the same day of testing.

Detailed Description

Four hours after breakfast a small amount of liquid to drink will be given to a participant that will contain either the Appethyl™ or placebo. Participants will be given a lunch of about 750 calories and 40% fat prepared by the Metabolic Kitchen and be asked to eat all of it. Participants will have food choice testing performed 4 hours after starting their lunch meal. This will be done in two ways. Participants will be given a list of two foods that are made of carbohydrate like bread and pretzels and be asked which is most preferred. Participants will also be given a list of foods that differ in the amounts of fat, carbohydrate and protein that they contain and will be asked to mark the ones that appeal to them.

Participants will be presented with a pizza in a quantity more than they could reasonably be expected to eat 5 hours after the start of their lunch meal and be asked to eat to their satisfaction over 30 minutes. Participants are not expected to eat all of the pizza.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • You are a male or female aged 18 to 65 years.
  • You have a BMI (a number calculated from your height and weight) between 25-35 kg/m2, inclusive.
  • Your waist circumference is over 35 inches.
Exclusion Criteria
  • You have been on a diet for weight loss in the last 2 months.
  • You are being treated for blood pressure, diabetes, heart disease, rheumatoid arthritis, or blood vessel disease.
  • You have a psychotic illness.
  • You have other chronic diseases like an inflammatory bowel disease such as Crohn's disease or ulcerative colitis.
  • You have a dysfunction of your gastrointestinal tract.
  • You have food allergies.
  • You have rheumatoid arthritis with inflammation.
  • You have chronic constipation.
  • You are taking any products to lose weight such as medication for obesity or non-prescription medications for weight loss.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Appethyl™, then PlaceboAppethyl™Participants receive Appethyl™ liquid once four hours after breakfast. After a washout period of at least one week, they received the placebo drink once four hours after breakfast.
Appethyl™, then PlaceboPlaceboParticipants receive Appethyl™ liquid once four hours after breakfast. After a washout period of at least one week, they received the placebo drink once four hours after breakfast.
Placebo, then Appethyl™Appethyl™Participants receive the placebo drink once four hours after breakfast. After a washout period of at least one week, they received Appethyl™ liquid once four hours after breakfast.
Placebo, then Appethyl™PlaceboParticipants receive the placebo drink once four hours after breakfast. After a washout period of at least one week, they received Appethyl™ liquid once four hours after breakfast.
Primary Outcome Measures
NameTimeMethod
Difference in Pizza Consumed During Two Meals5 hours after lunch (9 hours after administration of Appethyl from the morning)

Four hours after breakfast administration of Appethyl™ or placebo(inactive liquid) is given. You will be presented with a standard lunch and then (5 hours after lunch) pizza in a quantity of more than you could reasonably be expected to eat 5 hours after the start of your lunch meal and be asked to eat to your satisfaction over 30 minutes. You are not expected to eat all of the pizza.

Secondary Outcome Measures
NameTimeMethod
Evaluation of Appetite30 minutes, 60 minutes, 120 minutes after consuming the drug or placebo

The Visual Analogue scale allows you to mark a vertical line across the horizontal scale on how hungry you are or not. The Visual Analogue scale was used to evaluate hunger, fullness, longing for food, prospective intake, satisfaction, desire for salty food, desire for savory food, thirst, and desire for sweet food. The scale ranged from 0 to 100mm; the higher values indicated greater outcomes.

Evaluation of Satiety by Means of Visual Analogue Scale30 minutes, 60 minutes, 120 minutes after consuming the drug or placebo

The Visual Analogue scale allows you to mark a vertical line across the horizontal scale on how hungry you are or not. The Visual Analogue scale was used to evaluate hunger, fullness, longing for food, prospective intake, satisfaction, desire for salty food, desire for savory food, thirst, and desire for sweet food. The scale ranged from 0 to 100mm; the higher values indicated greater outcomes.

Trial Locations

Locations (1)

Pennington Biomedical Research Center

🇺🇸

Baton Rouge, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath